economic
Archived signal
Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
Reported by The Hindu
Read the complete report at The Hindu ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
4 reports · 4 sources
The HinduCentre to cap trade margins on non-scheduled cancer drugs to 30% of MRPThe HinduCentre to cap trade margins on non-scheduled cancer drugs to 30% of MRPTimes of IndiaGovt caps trade margins on non-scheduled anti-cancer drugs at 30% of MRPTimes of IndiaGovt caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP3 recorded states
Signal first indexedP1 · 84% quality · 4 sources
Quality 84→96P1 · 96% quality · 4 sources
Quality 96→99P1 · 99% quality · 4 sources